Caricamento...
Elevated XRCC5 expression level can promote temozolomide resistance and predict poor prognosis in glioblastoma
Drug resistance and disease recurrence are important contributors for the poor prognosis of glioblastoma multiforme (GBM). Temozolomide (TMZ), the standard chemotherapy for GBM treatment, can methylate DNA and cause the formation of double-strand breaks (DSBs). X-ray repair cross complementing 5 (XR...
Salvato in:
| Pubblicato in: | Oncol Lett |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
D.A. Spandidos
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8045174/ https://ncbi.nlm.nih.gov/pubmed/33868481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12704 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|